March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China. Under the deal, AstraZeneca will enter research ...

AstraZeneca has announced a $2.5bn investment to establish the company’s sixth worldwide strategic R&D centre in China.

(Bloomberg) -- AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was ...

AstraZeneca AZN-6.74%decrease ... pharmaceutical giant said Friday that it will build a new research center in Beijing, its sixth globally, that will focus on early-stage research and clinical ...

Pascal Soriot, AstraZeneca’s chief executive, says the investment ‘reflects our belief in the world-class life sciences ecosystem in Beijing’ - Zach Gibson/Bloomberg AstraZeneca has unveiled ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

This photo taken from Jingshan Hill on Aug. 12, 2024 shows the skyscrapers of the central business district (CBD) on a sunny ...

AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators ...